HUM · News · 20260806N
Medical Cost Trends
HUMANA INC · 2026-08-06 · Importance 17 · Surprise 24 · In source text
Health insurers reported improved second-quarter results after a difficult 2025, with Medicare Advantage medical costs described as stabilizing. Medicaid remains challenging because of upcoming work requirements and continued turbulence in ACA marketplaces. Analysts are monitoring whether insurers can sustain multi-year margin improvement and how star ratings litigation may affect competition in the Medicare Advantage market.
Key facts
- CVRx said Humana issued a new Medicare Advantage coverage policy for its Barostim therapy. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | committed | — | CVRx said Humana issued a new Medicare Advantage coverage policy for its Barostim therapy. |